Our long-term objectives are to clearly delineate the biochemical pathways which are triggered by the interaction between ligand and specific cell surface receptor and lead to modulation of macrophage functions. We will focus our efforts on the biochemical and biological properties of Fc-gamma- Rs present on the surface of murine macrophage, because many of macrophage functions, such as phagocytosis of opsonized particles, killing of tumor cells, presentation of antigens, and secretion of factors which regulate T and B cells, have been shown to require the participation of cell surface Fc-gamma-Rs.
Specific aims are to investigate: 1) physiological roles of casein kinase II (CKII) activity associated with Fc-gamma(2a)R; 2) properties of Fc-gamma(2a)R by biochemical and molecular biological approaches; 3) the roles of G proteins in the regulation of phospholipases C and A2 activated by immune complex or LPS; and 4) the role of cAMP-dependent protein kinase (cAK) and protein kinase C (PKC) in the regulation of macrophage functions. We will approach to these specific aims by: 1) biochemical characterization of Fc-gamma(2a)R complex; 2) cloning of the gene coding for Fc-gamma(2a)R by subtractive hybridization method; 3) characterization of Fc-gamma(2a)R-associated CKII activity; 4) investigation of Fc-gamma-R-cytoskeletal interaction during phagocytosis; 5) comparison of the nature of G proteins among macrophage cell lines; and 6) characterization of cAK and PKC. Results obtained are expected to promote our understanding of the biochemical pathways of signal transmittance, which are initially triggered by cell surface FC-gamma-R and leads to the regulation of macrophage functions.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA035977-09
Application #
3173492
Study Section
Experimental Immunology Study Section (EI)
Project Start
1984-06-01
Project End
1995-03-31
Budget Start
1992-04-01
Budget End
1993-03-31
Support Year
9
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Kansas
Department
Type
Schools of Medicine
DUNS #
016060860
City
Kansas City
State
KS
Country
United States
Zip Code
66160
Li, Y; Ito, N; Suzuki, T et al. (1995) Dexamethasone inhibits nitric oxide-mediated cytotoxicity via effects on both macrophages and target cells. Immunopharmacology 30:177-86
Muroi, M; Muroi, Y; Suzuki, T (1994) The binding of immobilized IgG2a to Fc gamma 2a receptor activates NF-kappa B via reactive oxygen intermediates and tumor necrosis factor-alpha 1. J Biol Chem 269:30561-8
Fujihara, M; Connolly, N; Ito, N et al. (1994) Properties of protein kinase C isoforms (beta II, epsilon, and zeta) in a macrophage cell line (J774) and their roles in LPS-induced nitric oxide production. J Immunol 152:1898-906
Fujihara, M; Ito, N; Pace, J L et al. (1994) Role of endogenous interferon-beta in lipopolysaccharide-triggered activation of the inducible nitric-oxide synthase gene in a mouse macrophage cell line, J774. J Biol Chem 269:12773-8
Fujihara, M; Muroi, M; Muroi, Y et al. (1993) Mechanism of lipopolysaccharide-triggered junB activation in a mouse macrophage-like cell line (J774). J Biol Chem 268:14898-905
Muroi, M; Suzuki, T (1993) Role of protein kinase A in LPS-induced activation of NF-kappa B proteins of a mouse macrophage-like cell line, J774. Cell Signal 5:289-98
Muroi, M; Muroi, Y; Yamamoto, K et al. (1993) Influence of 3' half-site sequence of NF-kappa B motifs on the binding of lipopolysaccharide-activatable macrophage NF-kappa B proteins. J Biol Chem 268:19534-9
Suzuki, T (1991) Signal transduction mechanisms through Fc gamma receptors on the mouse macrophage surface. FASEB J 5:187-93
Novotney, M; Chang, Z L; Uchiyama, H et al. (1991) Protein kinase C in tumoricidal activation of mouse macrophage cell lines. Biochemistry 30:5597-604
Yamada, A; Suzuki, T (1989) Fc gamma 2b receptor-mediated phagocytosis by a murine macrophage-like cell line (P388D1) and peritoneal resident macrophages. Up-regulation by the inhibitors of phospholipase A2 and cyclooxygenase. J Immunol 142:2457-63

Showing the most recent 10 out of 18 publications